Learn More
Cayman Chemical MK-4827tosylate 10mg

Supplier: Cayman Chemical 2084210 MG
An orally bioavailable inhibitor of PARP1 and PARP2 (IC50s = 3.8 and 2.1 nM, respectively); inhibits the proliferation of BRCA1 and BRCA2 mutant cancer cells in vitro (IC50s = 10-100 nM) and has efficacy alone against a xenograft of BRCA1-deficient cancer in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.